Optimized Lacosamide Nanostructured Lipid Carriers for Enhanced Brain Targeting Via the Intranasal Route
- 30 October 2025
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (6) , 1-19
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulationMedical Oncology, 2024
- On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticlesApplied Materials Today, 2022
- Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and TolerabilityCNS Drugs, 2022
- Chitosan as mucoadhesive polymer in drug delivery2022
- Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken designBiomedicine & Pharmacotherapy, 2021
- Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluationsDrug Delivery and Translational Research, 2021
- Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studiesActa Pharmaceutica Sinica B, 2021
- Distribution of lacosamide in the rat brain assessed by in vitro slice techniqueArchives of Pharmacal Research, 2017
- Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivationJournal of Neuroscience Research, 2012
- Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in ratsArchives of Pharmacal Research, 2011